A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)

NCT00770692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Eszopiclone 1 mg- Elderly
DRUG: Eszopiclone 2 mg- Elderly
DRUG: Eszopiclone 3 mg- Non-elderly
DRUG: Eszopiclone 2 mg- Non-elderly

Sponsor

Eisai Co., Ltd.